1. S. Safe, S. Bandiera, T. Sawyer, L. Robertson, L. Safe, A. Parkinson, P. E. Thomas, D. E. Ryan, L. M. Reik, W. Levin, M. A. Denomme, and T. Fujita, PCBs: Structure-function relationships and mechanisms of action, Environ. Health Perspect.
60, 47–66 (1985).
2. J. S. Bellin and D. G. Barnes, Interim procedures for estimating risks associated with exposure to mixtures of chlorinated dibenzo-p-dioxins and-dibenzofurans (CDDs and CDFs), EPA/625/3-89/016, Risk Assessment Forum, Washington, DC (1989).
3. A. Poland and J. C. Knutson, 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity, Annu. Rev. Pharmacol. Toxicol.
22, 517–554 (1982).
4. J. P. Whitlock, Jr., Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action, Annu. Rev. Pharmacol. Toxicol.
30, 251–277 (1990).
5. A. Poland, E. Glover, and A. S. Kende, Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol, J. Biol. Chem.
251, 4936–4946 (1976).